Synergy Pharmaceuticals buy tamam
Start price
18.03.17
/
50%
€4.56
Target price
22.05.17
€11.28
Performance (%)
-21.74%
End price
22.05.17
€3.57
Summary
This prediction ended on 22.05.17 with a price of €3.57. The prediction for Synergy Pharmaceuticals disappointed with a performance of -21.74%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Synergy Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % | 46,26 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % | 72,33 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % | 52,28 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % | 55,10 % |
Comments by tamam for this prediction
In the thread Synergy Pharmaceuticals diskutieren
tamam stimmt der Analystenmeinung von 'Buy' zu
Potential Catalysts: SNDA submission for Trulance for IBS-C.
Initial sales of Trulance.
Buyout Offer.
(Vom Mitglied beendet)
Stopped prediction by tamam for Synergy Pharmaceuticals
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€2.34
25.09.17
25.09.17
€6.31
13.12.18
13.12.18
-94.98%
13.12.18
13.12.18
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€5.93
06.10.15
06.10.15
€10.82
06.04.16
06.04.16
-57.53%
06.04.16
06.04.16